170 related articles for article (PubMed ID: 34981545)
1. Assessment of an online calculator's vancomycin dosing and exposure appropriateness in persons who inject drugs with methicillin-resistant Staphylococcus aureus bloodstream infections.
Opitz BJ; Housman ST; Housman EL; Lorenzo MP
J Clin Pharm Ther; 2022 Jun; 47(6):752-758. PubMed ID: 34981545
[TBL] [Abstract][Full Text] [Related]
2. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant
Song X; Han M
Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144
[TBL] [Abstract][Full Text] [Related]
4. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
[No Abstract] [Full Text] [Related]
6. Comparison of vancomycin area under the concentration-time curve (AUC) using two-point pharmacokinetics versus two open-access online single-concentration vancomycin calculators.
Ondrush NM; Ademovic R; Seabury RW; Darko W; Miller CD; Mogle BT
J Clin Pharm Ther; 2022 Dec; 47(12):2223-2229. PubMed ID: 36351763
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
Fewel N
J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
[TBL] [Abstract][Full Text] [Related]
8. Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.
Martirosov DM; Bidell MR; Pai MP; Scheetz MH; Rosenkranz SL; Faragon C; Malik M; Mendes RE; Jones RN; McNutt LA; Lodise TP
BMC Infect Dis; 2017 Aug; 17(1):534. PubMed ID: 28764660
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study.
Nolan J; McCarthy K; Farkas A; Avent ML
Int J Clin Pharm; 2023 Dec; 45(6):1444-1451. PubMed ID: 37532840
[TBL] [Abstract][Full Text] [Related]
10. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation.
Frymoyer A; Hersh AL; Coralic Z; Benet LZ; Joseph Guglielmo B
Clin Ther; 2010 Mar; 32(3):534-42. PubMed ID: 20399990
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?
Lodise TP; Drusano GL; Zasowski E; Dihmess A; Lazariu V; Cosler L; McNutt LA
Clin Infect Dis; 2014 Sep; 59(5):666-75. PubMed ID: 24867791
[TBL] [Abstract][Full Text] [Related]
12. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
Stockmann C; Olson J; Rashid J; Lubsch L; Young DC; Hersh AL; Frymoyer A; Ampofo K; Liu X; Wang Y; Sherwin CMT; Zobell JT
J Clin Pharmacol; 2019 Feb; 59(2):198-205. PubMed ID: 30371946
[TBL] [Abstract][Full Text] [Related]
13. Comparison of vancomycin area under the curve calculated based on Bayesian approach versus equation-based approach.
Lee E; Yu U; Park JI; Park SI
Int J Clin Pharmacol Ther; 2024 May; 62(5):204-212. PubMed ID: 38329916
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an AUC
Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
[TBL] [Abstract][Full Text] [Related]
15. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
Yoo R; So H; Seo E; Kim M; Lee J
PLoS One; 2021; 16(4):e0247714. PubMed ID: 33793589
[TBL] [Abstract][Full Text] [Related]
16. The relationship of vancomycin 24-hour AUC and trough concentration.
Nix DE; Davis LE; Matthias KR
Am J Health Syst Pharm; 2022 Mar; 79(7):534-539. PubMed ID: 34849533
[TBL] [Abstract][Full Text] [Related]
17. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
[TBL] [Abstract][Full Text] [Related]
18. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.
Frymoyer A; Hersh AL; Benet LZ; Guglielmo BJ
Pediatr Infect Dis J; 2009 May; 28(5):398-402. PubMed ID: 19295465
[TBL] [Abstract][Full Text] [Related]
19. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
Frymoyer A; Guglielmo BJ; Hersh AL
Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
[TBL] [Abstract][Full Text] [Related]
20. The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE).
Lodise TP; Rosenkranz SL; Finnemeyer M; Evans S; Sims M; Zervos MJ; Creech CB; Patel PC; Keefer M; Riska P; Silveira FP; Scheetz M; Wunderink RG; Rodriguez M; Schrank J; Bleasdale SC; Schultz S; Barron M; Stapleton A; Wray D; Chambers H; Fowler VG; Holland TL
Clin Infect Dis; 2020 Apr; 70(8):1536-1545. PubMed ID: 31157370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]